Page last updated: 2024-11-05

methdilazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methdilazine : A phenothiazine substituted on nitrogen by a (1-methylpyrrolidin-3-yl)methyl group; a first-generation antihistamine with anticholinergic properties. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14677
CHEMBL ID1200959
CHEBI ID6823
SCHEMBL ID121507
MeSH IDM0130254

Synonyms (71)

Synonym
10h-phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-
10h-phenothiazine, tannate (5:1)
nsc-244191
nsc244191
10-[(1-methylpyrrolidin-3-yl)methyl]-10h-phenothiazine
10-((1-methyl-3-pyrrolidinyl)methyl)-10h-phenothiazine
methdilazine (inn)
D04979
tacaryl (tn)
10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine
phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-
methdilazinum [inn-latin]
10-((1-methyl-3-pyrrolidinyl)methyl)phenothiazine
einecs 217-841-6
nci-c60720
metodilazina [inn-spanish]
10h-phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-
1982-37-2
methdilazine
C07175
DB00902
tacaryl
NCI60_001351
PDSP1_000149
PDSP2_000148
CHEMBL1200959
chebi:6823 ,
L001130
nsc_14677
bdbm81470
cas_14677
unii-4q13ly9z8x
metodilazina
methdilazinum
methdilazine [usp:inn:ban]
4q13ly9z8x ,
tacryl
methodilazine
tacazyl
methdilazine [mi]
methdilazine [vandf]
methdilazine [inn]
methdilazine [mart.]
methdilazine [orange book]
methdilazine [who-dd]
10-[(1-methyl-3-pyrrolidinyl)methyl]phenothiazine
gtpl7231
SCHEMBL121507
metdilazina
10-[(1-methyl-3-pyrrolidinyl)methyl]-10h-phenothiazine #
phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-
disyncran (salt/mix)
dilosyn (salt/mix)
disyncram (salt/mix)
DTXSID6023282 ,
SR-01000944494-1
sr-01000944494
Q6665709
methdilazine (200 mg)
10-[(1-methyl-3-pyrrolidinyl)methyl]phenothiazine; mj 5022
methdilazine(200mg)
EN300-18552794
CS-0013673
HY-B1690
metodilazina (inn-spanish)
dtxcid903282
10-((1-methylpyrrolidin-3-yl)methyl)-10h-phenothiazine
methdilazinum (inn-latin)
r06ad04
methdilazine (usp:inn:ban)
methdilazine (mart.)

Research Excerpts

Actions

ExcerptReferenceRelevance
"Methdilazine (Md) could inhibit various Mycobacterium spp. "( Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine.
Bhattacharya, CP; Chakrabarty, AN; Dastidar, SG, 1993
)
2.02

Compound-Compound Interactions

The H1 blockers, including an ethylenediamine (pyrilamine), an ethanolamine (diphenhydramine), a phenothiazine (methdilazine), a piperazine (cyclizine) and an alkylamine (chlorpheniramine), all produced antinociception when given alone to mice. They also caused potentiation when combined with morphine.

ExcerptReferenceRelevance
" A high degree of synergism was observed in vitro when Pz was used in combination with methdilazine and bromodiphenhydramine."( Drug interaction of promethazine & other non-conventional antimicrobial chemotherapeutic agents.
Acharya, DP; Chakrabarty, AN; Dastidar, SG; Neogi, D, 1989
)
0.5
" The H1 blockers, including an ethylenediamine (pyrilamine), an ethanolamine (diphenhydramine), a phenothiazine (methdilazine), a piperazine (cyclizine) and an alkylamine (chlorpheniramine), all produced antinociception when given alone to mice and also caused potentiation when combined with morphine."( Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice.
Hanig, JP; Hui, FW; Sun, CL, 1985
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
histamine antagonistHistamine antagonists are the drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists.
cholinergic antagonistAny drug that binds to but does not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.
antipruritic drugA drug, usually applied topically, that relieves pruritus (itching).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenothiazines
N-alkylpyrrolidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Methdilazine H1-Antihistamine Action87

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1364924Selectivity index, ratio of CC50 for BHK cells to IC50 for Chikungunya virus LR2006 OPY12017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
The medicinal chemistry of Chikungunya virus.
AID1364913Antiviral activity against Chikungunya virus LR2006 OPY1 infected in BHK cells measured at 14 hrs post infection by luciferase reporter gene assay2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
The medicinal chemistry of Chikungunya virus.
AID1364923Cytotoxicity against BHK cells assessed as reduction in cell viability after 48 hrs in presence of ATP by Celltiter-Glo luminescent assay2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
The medicinal chemistry of Chikungunya virus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (57.14)18.7374
1990's3 (14.29)18.2507
2000's4 (19.05)29.6817
2010's2 (9.52)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.60 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.23 (4.65)
Search Engine Demand Index40.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]